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Background: Living related kidney transplantation (LRT) is underutilized, particularly among African Americans.
The effectiveness of informational and financial interventions to enhance informed decision-making among African
Americans with end stage renal disease (ESRD) and improve rates of LRT is unknown.
Methods/design: We report the protocol of the Providing Resources to Enhance African American Patients’
Readiness to Make Decisions about Kidney Disease (PREPARED) Study, a two-phase study utilizing qualitative and
quantitative research methods to design and test the effectiveness of informational (focused on shared
decision-making) and financial interventions to overcome barriers to pursuit of LRT among African American
patients and their families. Study Phase I involved the evidence-based development of informational materials as
well as a financial intervention to enhance African American patients’ and families’ proficiency in shared
decision-making regarding LRT. In Study Phase 2, we are currently conducting a randomized controlled trial in
which patients with new-onset ESRD receive 1) usual dialysis care by their nephrologists, 2) the informational
intervention (educational video and handbook), or 3) the informational intervention in addition to the option of
participating in a live kidney donor financial assistance program. The primary outcome of the randomized
controlled trial will include patients’ self-reported rates of consideration of LRT (including family discussions of LRT,
patient-physician discussions of LRT, and identification of a LRT donor).
Discussion: Results from the PREPARED study will provide needed evidence on ways to enhance the decision to
pursue LRT among African American patients with ESRD.
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African Americans are less likely than Whites to receive
kidney transplants, despite their up to four-fold greater
likelihood to develop end stage renal disease (ESRD) [1].
Several factors contribute to lower rates of kidney trans-
plantation for African Americans, including immuno-
logical incompatibility of deceased donor kidneys [2,3],
lower rates of referral of African Americans for trans-
plantation [4-6], lower rates of deceased kidney donation
[7], less access to health care [5,8], less desire for kidney
transplantation [9,10], and suboptimal discussions about
living related kidney transplantation (LRT) between reci-
pients, their families, and health care providers [11].
LRT offers patients an opportunity to bypass many bar-
riers to receipt of deceased kidney transplants, and it
improves survival and quality of life at a lesser cost than
dialysis care [12-16]. However, African Americans are
less likely than Whites to receive LRTs, further exacer-
bating race disparities in transplant rates [17].
African Americans’ poor awareness of the risks and
benefits of LRT as well as their limited access to poten-
tial live kidney donors represent important potential bar-
riers to their receipt of LRT [18]. Evidence suggests
African Americans are less likely than their White coun-
terparts to be aware of LRT as a treatment option, even
when they are under the care of a nephrologist [19,20].
Evidence also suggests African Americans have difficulty
identifying potential live kidney donors that successfully
complete the donation process [21]. Lack of financial as-
sistance with indirect costs associated with LRT, such as
expenses from travel/lodging, lost work, and home
health assistance for donors may pose a significant bar-
rier to live kidney donation, particularly among African
Americans [22]. A recent study of the general public
identified that potential living donors concerned about
out of pocket expenses related to donation had 50%
lesser odds of being willing to donate when compared to
persons not concerned about expenses [23]. In a separ-
ate study, an overwhelming majority of the U.S. general
public reported having favorable attitudes toward finan-
cial assistance programs which could help cover indirect
costs for living donors, including costs associated with
leave from work, with African Americans reporting sig-
nificantly more favorable attitudes towards some forms
of financial assistance when compared to Whites [24].
To date, however, it is unknown whether educational or
financial assistance to address gaps in patients’ know-
ledge and financial barriers to receipt of LRT could be
effective mechanisms of improving African Americans’
access to this life-saving therapy.
We describe the protocol of a two-phase study in
which we 1) developed informational and financial inter-
ventions to enhance African Americans’ shared and
informed decision-making about LRT and 2) arecurrently testing the effectiveness of these interventions
in a randomized controlled trial.
Methods/design
Study design summary
The Providing Resources to Enhance African American
Patients’ Readiness to Make Decisions about Kidney Dis-
ease (PREPARED) Study is a two-phase study to design
and test the effectiveness of informational and financial
interventions to overcome barriers to pursuit of LRT
among African American patients and families. In Phase
1, we developed an informational intervention, including
an educational video and handbook, to assist patients
with new-onset ESRD and their families with informed
decision-making regarding the choice of LRT and other
renal replacement therapy options. We also developed a
financial assistance intervention for potential live kidney
donors identified by patients with ESRD, which we
adapted from an existing national program [25]. In Phase
2, we are currently conducting a randomized controlled
trial to assess the individual and combined effectiveness
of informational and financial interventions on patients’
and their families’ consideration or pursuit of LRT as a
treatment. The Johns Hopkins School of Medicine Insti-
tutional Review Board has approved all study procedures.
Phase I: Development of informational and financial
assistance interventions
To inform the development of informational interven-
tions, we performed qualitative focus groups as well as
directed interviews of patients with kidney disease and
their family members. Full details have been previously
published [26]. We also performed systematic reviews
of scientific evidence describing the risks and benefits
of LRT compared to other forms of renal replacement
therapy [27-30]. We reviewed the published literature
describing ethical and legal forms of potential financial
assistance for patients and living donors seeking LRT
(e.g. reimbursement for childcare expenses, lodging/
travel expenses, and time lost from work) to inform
intervention development [31-40]. We also reviewed
publicly available information on a national live donor
financial assistance program to inform the development
of our donor financial assistance intervention [25]. We
performed several iterative revisions of informational
materials, incorporating feedback from patients with
kidney disease and their family members.
Description of informational intervention
The informational intervention consists of an educational
video and written handbook that we designed to assist
patients with kidney disease (potential transplant recipi-
ents) and their family members (potential donors) with
making informed decisions about LRT. The informational
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donors to a variety of experiences of others receiving vari-
ous forms for renal replacement therapy, including LRT.
The educational video features patients and their family
members describing their experiences with LRT as well as
with other forms of renal replacement therapy (peritoneal
dialysis, home hemodialysis, in-center hemodialysis, and
medical management with no dialysis or transplant). The
educational video also features medical professionals (a
transplant nephrologist, a transplant social worker, a gen-
eral nephrologist and a dialysis social worker) describing
positive and negative experiences patients could have with
the various forms of renal replacement therapy. The writ-
ten handbook provides a summary of scientific evidence
describing the risks and benefits of LRT and other forms
of renal replacement therapy in lay language. Together,
the educational video and handbook promote shared and
informed decision-making regarding LRT on the part of
patients, their families, and health care providers by
achieving commonly accepted goals for informational
shared decision-making aids [41].
Description of the financial assistance intervention
We will offer potential recipients the opportunity to enroll
their family members or friends (potential donors) in a
program that will reimburse potential donors up to
$1600.00 for approved financial assistance through the
study by submitting formal original invoices, receipts, and
other documentation of their qualifying medical and non-
medical expenses related to live kidney donation evalu-
ation, donation, or convalescence (up to 10 weeks post live
donor/LRT procedures). Qualifying expenses include
travel/lodging, meals, incidental expenses (e.g., parking),
lost wages, and childcare costs incurred by the potential
donor as part of: (1) donor evaluation, clinic visit or
hospitalization, (2) hospitalization for the living donor sur-
gical procedure, and/or (3) medical or surgical follow-up
clinic visits or hospitalization within 90 days following the
living donation procedure. Participants will be permitted
to utilize the $1600.00 for multiple approved purposes, as
long as the total reimbursement is not greater than
$1600.00. Also, more than one potential donor may draw
from these funds, as long as the total value of reimbursed
expenses does not exceed $1600.00 per patient study par-
ticipant. This program covers a broader array of expenses
related to live kidney donation than other national pro-
grams and does not limit reimbursement of potential
donors based on their personal incomes.
Phase 2: Randomized controlled trial assessing the
individual and combined effectiveness of informational
and financial interventions
We are currently conducting a randomized controlled
trial to assess the individual and combined effectivenessof informational and financial assistance interventions to
enhance rates of LRT. The combined intervention will
be tested to detect any additive or multiplicative effects
of the financial assistance intervention. Recruitment of
study participants began in August, 2012. Figure 1 con-
tains a flow diagram demonstrating the overall structure
of our study.
Target population and eligibility criteria
Our population includes English-speaking African
American patients with ESRD who are age 18 years or
older and who have initiated dialysis within one year
prior to study enrollment. We exclude participants if
they have dementia (assessed in-person) [42] or if they
have a self reported history of prior kidney transplant,
cancer within 2 years prior to recruitment, stage IV con-
gestive heart failure, end stage liver disease, pulmonary
hypertension, severe peripheral vascular disease, or
chronic (debilitating) infections. We assess participants’
eligibility via questions administered by a research assist-
ant in-person in dialysis units. After potentially eligible
patients agree to participate, we request a release of
medical records from each participant to confirm their
eligibility for the study and to ascertain whether poten-
tial donors have contacted local transplant centers to be
evaluated as donors on behalf of participants.
Recruitment of participants
We recruit participants from academically affiliated and
community-based dialysis centers in the Baltimore, MD
metropolitan region, which we have selected to provide
an adequate number of African American participants
with new-onset ESRD. We recruit patients on-site from
different dialysis centers on different days. We system-
atically rotate recruitment days at sites so variations in
patient scheduling at all sites can be covered to achieve
the maximum number of recruitment opportunities.
Upon confirmation of their eligibility to participate, we
randomly assign patients into intervention groups.
Reimbursement and enrollment of potential kidney donors
Potential kidney donors only become aware of the finan-
cial assistance program through direct referral by en-
rolled study participants. Research study staff do not
contact or attempt to contact any family, friends, or
acquaintances of enrolled patient participants. Therefore,
enrolled participants will be directed to contact study
staff in the event they want to refer potential donors to
the program. To be eligible to participate, potential
donors must speak English and be 18 years or older.
Once potential donors contact study staff, study staff
arrange for a time to meet with the potential donor(s)
in person and mail them the brochure describing the fi-
nancial assistance program. At that time, study staff
Clinical Site Selection
Baseline Interviews
(in Person, Telephone)
Usual Care PREPARED 
Information
PREPARED Information 
plus Financial Assistance
Usual Care in 
Dialysis Facility
Informational 
Audiovisual and 
Written Materials 
about Renal 
Replacement 
Therapy
Informational Audiovisual 
and Written Materials at 
Baseline Plus Financial 
Assistance to Potential 
Donors for Donor 
Evaluation Costs or 
Donation Costs
Follow up for 6 months
Data Analysis
Informed consent,
Apply Inclusion criteria,  
Exclusion criteria
Figure 1 Flow of PREPARED Study Activities.
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donors, including what they will be asked to do as part
of the study. Potential donors are notified that partici-
pation in the financial assistance program offered by
the study may preclude them from receiving financial
assistance from any other program (e.g., National Living
Donor Assistance Center). If potential donors wish to
participate in the financial assistance program, we ob-
tain consent for their participation in the study using
approved consent procedures.
Randomization
Using blind and secure allocation by computer, we ran-
domly assign participants to one of three intervention
arms: 1) control group (“Usual Care”, N=70); 2) the in-
formational intervention (“PREPARED”, N=70); and 3)
the informational plus the financial assistance interven-
tions (“PREPARED plus Financial Assistance”, N=70).
Randomization is blocked by recruitment site to ensure
equal allocation within each dialysis facility.
Usual care group
Participants randomly assigned to receive Usual Care
proceed with their clinical care in dialysis centers asalready routinely implemented by their physicians. At
study conclusion, participants will receive informational
materials provided in PREPARED (educational video and
written handbook) after follow up assessments have
been completed.Intervention groups
Participants randomly assigned to the PREPARED pro-
gram receive the informational intervention, which con-
sists of an educational video and written handbook
intended to be used together to inform patients’ deci-
sions about their kidney disease treatment choices. These
materials are provided to participants on a day when they
do not receive dialysis in the dialysis center. Participants
meet with trained research study staff during which time
they are oriented to the book and watch the video. Study
staff members also encourage participants to share the
materials with their families and health care providers.
Participants randomly assigned to the PREPARED plus
Financial Assistance program receive the informational
intervention at the time of enrollment in a similar fash-
ion with a similar approach to the PREPARED assign-
ment. In addition, participants in this group are invited
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program as described above.
Data collection, follow-Up and outcomes
Measures assessed through interventions
All patient participants enrolled in the study are assessed
using an in-person questionnaire at the time of recruit-
ment and a structured telephone interview at baseline,
1 month, 3 months, and 6 months. Trained study staff
administer all telephone interviews. For the informa-
tional and financial intervention arms, participants are
contacted via telephone to determine whether they have
viewed the materials provided to them (an educational
video and written handbook for the informational inter-
vention and the brochure for the financial intervention
arm) again at home. Participants are also asked if they
have shared or discussed the content of intervention
materials with family members.
The primary outcome of interest is patients’ pursuit of
LRT over six months of follow up. This outcome is mea-
sured as participants’ achievement of at least one of six
key steps toward pursuing LRT, including: 1) execution
of patient-family discussions about LRT; 2) execution of
patient-physician discussions about LRT; 3) initiation of
the recipient evaluation for LRT; 4) completion of the
recipient evaluation for LRT, 5) identification of a poten-
tial live kidney donor, and 6) being listed at a transplant
center. Pursuit of LRT will be assessed via question-
naires administered via telephone questionnaire at base-
line, 1 month, 3 months and 6 months follow-up time
periods. For participants reporting being registered on a
transplant waiting list, we will contact transplant centers
to determine whether there have been any live donor in-
quiries on behalf of the participant. We will also assess
whether patient participants receive LRT and whether
patient participants’ family members inquire about or
use the financial assistance program (for those rando-
mized to the PREPARED plus Financial Assistance arm).
Other measures include assessment of participants’
(1) knowledge of LRT; (2) interest in LRT; (3) per-
ceived barriers to LRT; (4) preferred role in decision-
making about LRT; (5) concerns about the risks of
LRT to themselves and to donors [43-45]; (6) family
structure and relationships [46]; (7) interest in other
forms of renal replacement therapy (i.e., peritoneal dia-
lysis or home-hemodialysis); (8) satisfaction with
hemodialysis therapy; (9) depression and social support
[47,48]; (10) financial stress [49]; (11) health literacy
[50] and numeracy [51,52]; (12) trust in the medical
system [53,54], (13) comorbid conditions [55] and (14)
sociodemographic characteristics. For patient partici-
pants assigned to the PREPARED and PREPARED plus
Financial Assistance groups, we also assess their per-
ceptions of the helpfulness of the video and handbook.In all study groups, we also assess the number of
donor inquiries on behalf of study participants at local
transplant centers (Table 1).
Statistical considerations
Data analysis
Randomly assigned intervention group (i.e. Usual Care,
PREPARED, PREPARED plus Financial Assistance) will
be the main independent variable for intent-to-treat ana-
lyses. In our primary analyses, we will assess the propor-
tion of participants in each group achieving at least one
new LRT pursuit behavior over 6 months. We will use
multivariable models (e.g. logistic regression) to assess
differences in the odds of achieving LRT pursuit beha-
viors among study groups while adjusting for study site
characteristics and other baseline characteristics found
not to be balanced by randomization. Secondary analyses
will include exploratory analyses among persons within
subgroups defined post-randomization–for example,
analyses among persons with greater versus lesser know-
ledge of LRT at baseline. We will conduct primary ana-
lyses under the assumption that data is missing at
random, however, we will also perform sensitivity ana-
lyses based on other scenarios (i.e. patterns of missing
data) to evaluate the robustness of our assumptions.
Sample size and power
We are aware of no other randomized controlled trials
evaluating the effectiveness of informational (focused on
shared decision-making) or financial interventions on
commitment to LRT in incident dialysis patients. In our
own work, an educational intervention resulted in
patients’ greater pursuit of LRT (30% achieving new LRT
behavior in Usual Care arm compared to 50% in educa-
tion arm over 6 months) [19]. Our own previous work
also demonstrated African Americans in the US general
public were supportive of live kidney donors receiving
reimbursement for expenses related to donation [24].
We anticipate the financial intervention, which addresses
a common and tangible barrier to live kidney donation,
may improve pursuit of LRT by an additional 10%. Based
on these assumptions, we will have over 80% power to
detect a trend of increasing pursuit of LRT across groups
(e.g., 30% in Usual Care, 50% in PREPARED group, 60%
in PREPARED plus Financial Assistance group) at
6 months. We will also have over 80% power to detect a
30% difference between the PREPARED group and the
Usual Care group or the PREPARED plus Financial As-
sistance group and the Usual Care group individually
with correction for multiple comparisons.
Discussion
Inadequate resources to promote shared decision-
making about LRT and financial barriers to live kidney
Table 1 Data collected at study baseline and follow up
PATIENT
Measure Baseline 1 3 6
Month Month Month
Current Treatment Information
Date and Place of Initiation of Dialysis X
Presence of AV* Fistula or AV Graft X
Presence of Peritoneal Catheter X X X X
Exposure to Information about Kidney Disease Treatment
In Center Hemodialysis Information X X X X
Home Hemodialysis Information X X X X
Peritoneal Dialysis Information X X X X
Kidney Transplant Information X X X X
Live Donor Kidney Transplant Information X X X X
Discussions with Health Care Providers about Kidney Disease Treatment
Occurrence of Physician Discussions-Nephrologists X
Satisfaction with Patient-Physician Discussions X
Physician Recommendations Regarding LRT* X
Belief & Knowledge about Treatment for Kidney Failure, Interest in LRT
Beliefs About Treatment for Kidney Failure X X X X
Knowledge of LRT X X X X
Interest in LRT X X X X
Consideration of LRT (stage placement) X X X X
Elements of Shared Decision Making
Stage in Decision Making [43] X X X X
Decision Self-Efficacy [43] X X X X
Decisional Conflict Scale [44] X X X X
Interest in Switching Renal Replacement Therapy
Pursuit of LRT, Barriers to Completing Behavior Stages
Quality of Family Discussion X X X X
Information on Donor X X X X
Barriers to Patient-Family Discussion X X X X
Barriers to Patient-Physician Discussion X X X X
Barriers to Starting Evaluation X X X X
Barriers to Completing Evaluation X X X X
Mediators and Correlates of Pursuit of LRT
Trust in Medical Care [53,54] X
In-Center Dialysis Care - Nephrologist Communication, Receipt of Information X X X X
Family Functioning [46] X
Depressed Mood PRIME-MD/PHQ* [48] X X X
Social Function - Emotional Support, Instrumental Support, Informational
Support, Social Isolation [47]
X
Personal Financial Well-being Scale [49] X
Charlson Comorbidity Index [55] X
Sociodemographic Information X
Assessment of Book and Video
Assessment of Book and Video X X X
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Health Literacy and Numeracy
Rapid Estimate of Adult Literacy in Medicine (REALM) [50] X
Subjective Numeracy and Risk Numeracy [51,52] X
*Abbreviations are as follows: living related kidney transplantation (LRT); arteriovenous (AV); primary care evaluation of mental disorders/patient health
questionnaire (PRIME-MD/PHQ).
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African American compared to Whites [56-58]. We
designed PREPARED educational interventions to dir-
ectly address commonly encountered barriers to African
American patients and their family members and health
care providers in engaging in informed and shared
decision-making regarding pursuit of LRT. We designed
the PREPARED plus Financial Assistance intervention to
enable patients and their families to overcome the sig-
nificant barrier of monetary concerns in pursuit of LRT.
Rigorous study of these interventions will provide health
care providers and policy makers with the evidence ne-
cessary to endorse the widespread use of similar inter-
ventions in a variety of clinical settings if they are
effective.
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